Top Markets
Coin of the day
Life Stem Genetics Inc. Life Stem Genetics Inc.

Life Stem Genetics Inc.

LIFS
Rang in aandelen #42117
Life Stem Genetics Inc., an enterprise currently in its development phase, is... Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung diseases, as well as hyperbaric oxygen therapy. Life Stem Genetics Inc. maintains a strategic collaborative agreement with American CryoStem Corporation. This company was founded in 2012 and operates from its base in Beverly Hills, California.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2026-08-12
Marktkapitalisatie
$4.58K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Life Stem Genetics Inc. (LIFS)

Categorie

Dividendrendementgeschiedenis voor Life Stem Genetics Inc. (LIFS)
Het dividendrendement (TTM) van Life Stem Genetics Inc. (aandelsymbool: LIFS) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Life Stem Genetics Inc. (LIFS) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten